Literature DB >> 30489000

Let's cross-link: diverse functions of the promiscuous cellular transglutaminase factor XIII-A.

J L Mitchell1, N J Mutch2.   

Abstract

Essentials Plasma Factor XIII, a heterodimer of A and B subunits FXIIIA2 B2 , is a transglutaminase enzyme with a well-established role in haemostasis. Cells of bone marrow and mesenchymal lineage express the FXIII-A gene (F13A1) that encodes the cellular form of the transglutaminase, a homodimer of the A subunits, FXIII-A. FXIII-A was presumed to function intracellularly, however, several lines of evidence now indicate that FXIII-A is externalised by an as yet unknown mechanism This review describes the mounting evidence that FXIII-A is a diverse transglutaminase with many intracellular and extracellular substrates that can participate in an array of biological processes
SUMMARY: Factor XIII is a tranglutaminase enzyme that catalyzes the formation of ε-(γ-glutamyl)lysyl isopeptide bonds in protein substrates. The plasma form, FXIII-A2 B2 , has an established function in hemostasis, where its primary substrate is fibrin. A deficiency in FXIII manifests as a severe bleeding diathesis, underscoring its importance in this pathway. The cellular form of the enzyme, a homodimer of the A-subunits, denoted FXIII-A, has not been studied in as extensive detail. FXIII-A was generally perceived to remain intracellular, owing to the lack of a classical signal peptide for its release. In the last decade, emerging evidence has revealed that this diverse transglutaminase can be externalized from cells, by an as yet unknown mechanism, and can cross-link extracellular substrates and participate in a number of diverse pathways. The FXIII-A gene (F13A1) is expressed in cells of bone marrow and mesenchymal lineage, notably megakaryocytes, monocytes/macrophages, dendritic cells, chrondrocytes, osteoblasts, and preadipocytes. The biological processes that FXIII-A is coupled with, such as wound healing, phagocytosis, and bone and matrix remodeling, reflect its expression in these cell types. This review describes the mounting evidence that this cellular transglutaminase can be externalized, usually in response to stimuli, and participate in extracellular cross-linking reactions. A corollary of being involved in these biological pathways is the participation of FXIII-A in pathological processes. In conclusion, the functions of this transglutaminase extend far beyond its role in hemostasis, and our understanding of this enzyme in terms of its secretion, regulation and substrates is in its infancy.
© 2018 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  zzm321990F13A1zzm321990; cellular; cross-link; factor XIII; transglutaminases

Mesh:

Substances:

Year:  2019        PMID: 30489000     DOI: 10.1111/jth.14348

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  13 in total

1.  Factor XIII topology: organization of B subunits and changes with activation studied with single-molecule atomic force microscopy.

Authors:  Anna D Protopopova; Andrea Ramirez; Dmitry V Klinov; Rustem I Litvinov; John W Weisel
Journal:  J Thromb Haemost       Date:  2019-03-14       Impact factor: 5.824

2.  Proteolytic and nonproteolytic activation mechanisms result in conformationally and functionally different forms of coagulation factor XIII A.

Authors:  Boris A Anokhin; William L Dean; Kerrie A Smith; Matthew J Flick; Robert A S Ariëns; Helen Philippou; Muriel C Maurer
Journal:  FEBS J       Date:  2019-08-28       Impact factor: 5.542

3.  Coagulation FXIII-A Protein Expression Defines Three Novel Sub-populations in Pediatric B-Cell Progenitor Acute Lymphoblastic Leukemia Characterized by Distinct Gene Expression Signatures.

Authors:  Katalin Gyurina; Bettina Kárai; Anikó Ujfalusi; Zsuzsanna Hevessy; Gábor Barna; Pál Jáksó; Gyöngyi Pálfi-Mészáros; Szilárd Póliska; Beáta Scholtz; János Kappelmayer; Gábor Zahuczky; Csongor Kiss
Journal:  Front Oncol       Date:  2019-10-25       Impact factor: 6.244

4.  Transglutaminases and Obesity in Humans: Association of F13A1 to Adipocyte Hypertrophy and Adipose Tissue Immune Response.

Authors:  Mari T Kaartinen; Mansi Arora; Sini Heinonen; Aila Rissanen; Jaakko Kaprio; Kirsi H Pietiläinen
Journal:  Int J Mol Sci       Date:  2020-11-05       Impact factor: 5.923

5.  Clinical Validation of an Automated Fluorogenic Factor XIII Activity Assay Based on Isopeptidase Activity.

Authors:  Martina Leitner; Christian Büchold; Ralf Pasternack; Nikolaus B Binder; Gary W Moore
Journal:  Int J Mol Sci       Date:  2021-01-20       Impact factor: 5.923

6.  Coagulation Factor XIII Subunit A Is a Biomarker for Curative Effects and Prognosis in Malignant Solid Tumors, Especially Non-small Cell Lung Cancer.

Authors:  Yujiao Luo; Bin Li; Ji Li; Yang Zhang; Mingyang Deng; Chunhong Hu; Wenzhe Yan; Zhiguang Zhou; Guangsen Zhang
Journal:  Front Oncol       Date:  2021-12-15       Impact factor: 6.244

7.  F13A1 transglutaminase expression in human adipose tissue increases in acquired excess weight and associates with inflammatory status of adipocytes.

Authors:  M T Kaartinen; M Arora; S Heinonen; A Hang; A Barry; J Lundbom; A Hakkarainen; N Lundholm; A Rissanen; J Kaprio; K H Pietiläinen
Journal:  Int J Obes (Lond)       Date:  2020-11-21       Impact factor: 5.095

8.  Coagulation, inflammation, and CD46 transgene expression in neonatal porcine islet xenotransplantation.

Authors:  Mingqing Song; Zachary W Fitch; Kannan P Samy; Benjamin M Martin; Qimeng Gao; Robert Patrick Davis; Francis V Leopardi; Niki Huffman; Robin Schmitz; Gayathri R Devi; Bradley H Collins; Allan D Kirk
Journal:  Xenotransplantation       Date:  2021-02-22       Impact factor: 3.907

9.  TCF21+ mesenchymal cells contribute to testis somatic cell development, homeostasis, and regeneration in mice.

Authors:  Yu-Chi Shen; Adrienne Niederriter Shami; Lindsay Moritz; Hailey Larose; Gabriel L Manske; Qianyi Ma; Xianing Zheng; Meena Sukhwani; Michael Czerwinski; Caleb Sultan; Haolin Chen; Stephen J Gurczynski; Jason R Spence; Kyle E Orwig; Michelle Tallquist; Jun Z Li; Saher Sue Hammoud
Journal:  Nat Commun       Date:  2021-06-23       Impact factor: 14.919

10.  Deletion of Coagulation Factor IX Compromises Bone Mass and Strength: Murine Model of Hemophilia B (Christmas Disease).

Authors:  Emily A Larson; Hillary J Larson; Jason A Taylor; Robert F Klein
Journal:  Calcif Tissue Int       Date:  2021-06-12       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.